These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 9234682

  • 1. Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy.
    Bontron S, Ucla C, Mach B, Steimle V.
    Mol Cell Biol; 1997 Aug; 17(8):4249-58. PubMed ID: 9234682
    [Abstract] [Full Text] [Related]

  • 2. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
    Lu HT, Riley JL, Babcock GT, Huston M, Stark GR, Boss JM, Ransohoff RM.
    J Exp Med; 1995 Nov 01; 182(5):1517-25. PubMed ID: 7595221
    [Abstract] [Full Text] [Related]

  • 3. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant.
    Zhou H, Su HS, Zhang X, Douhan J, Glimcher LH.
    J Immunol; 1997 May 15; 158(10):4741-9. PubMed ID: 9144488
    [Abstract] [Full Text] [Related]

  • 4. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
    Liu A, Takahashi M, Toba K, Zheng Z, Hashimoto S, Nikkuni K, Furukawa T, Koike T, Aizawa Y.
    Hematol Oncol; 1999 Dec 15; 17(4):149-60. PubMed ID: 10725870
    [Abstract] [Full Text] [Related]

  • 5. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
    Hake SB, Masternak K, Kammerbauer C, Janzen C, Reith W, Steimle V.
    Mol Cell Biol; 2000 Oct 15; 20(20):7716-25. PubMed ID: 11003667
    [Abstract] [Full Text] [Related]

  • 6. Suppression of human anti-porcine T-cell immune responses by major histocompatibility complex class II transactivator constructs lacking the amino terminal domain.
    Yun S, Gustafsson K, Fabre JW.
    Transplantation; 1998 Jul 15; 66(1):103-11. PubMed ID: 9679829
    [Abstract] [Full Text] [Related]

  • 7. Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene.
    Peijnenburg A, Van den Berg R, Van Eggermond MJ, Sanal O, Vossen JM, Lennon AM, Alcaïde-Loridan C, Van den Elsen PJ.
    Immunogenetics; 2000 Jan 15; 51(1):42-9. PubMed ID: 10663561
    [Abstract] [Full Text] [Related]

  • 8. Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants.
    Chin KC, Li GG, Ting JP.
    Proc Natl Acad Sci U S A; 1997 Mar 18; 94(6):2501-6. PubMed ID: 9122224
    [Abstract] [Full Text] [Related]

  • 9. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.
    Butticè G, Miller J, Wang L, Smith BD.
    Circ Res; 2006 Mar 03; 98(4):472-9. PubMed ID: 16439692
    [Abstract] [Full Text] [Related]

  • 10. Structural and functional characteristics of a dominant-negative isoform of porcine MHC class II transactivator.
    Quinn G, Bower R, Dos-Santos Cruz G, Giovino M, Xu Y, Patience C, Schuurman HJ.
    Eur J Immunogenet; 2003 Aug 03; 30(4):259-70. PubMed ID: 12919287
    [Abstract] [Full Text] [Related]

  • 11. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.
    Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B.
    Science; 1994 Jul 01; 265(5168):106-9. PubMed ID: 8016643
    [Abstract] [Full Text] [Related]

  • 12. Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression.
    Zika E, Fauquier L, Vandel L, Ting JP.
    Proc Natl Acad Sci U S A; 2005 Nov 08; 102(45):16321-6. PubMed ID: 16254053
    [Abstract] [Full Text] [Related]

  • 13. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W, Tang LP, Dong Y, Benveniste EN.
    J Immunol; 1999 Jan 15; 162(2):886-96. PubMed ID: 9916712
    [Abstract] [Full Text] [Related]

  • 14. Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas.
    Kanaseki T, Ikeda H, Takamura Y, Toyota M, Hirohashi Y, Tokino T, Himi T, Sato N.
    J Immunol; 2003 May 15; 170(10):4980-5. PubMed ID: 12734341
    [Abstract] [Full Text] [Related]

  • 15. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
    Chin KC, Mao C, Skinner C, Riley JL, Wright KL, Moreno CS, Stark GR, Boss JM, Ting JP.
    Immunity; 1994 Nov 15; 1(8):687-97. PubMed ID: 7600294
    [Abstract] [Full Text] [Related]

  • 16. The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.
    Kwak B, Mulhaupt F, Veillard N, Pelli G, Mach F.
    Swiss Med Wkly; 2001 Jan 27; 131(3-4):41-6. PubMed ID: 11219190
    [Abstract] [Full Text] [Related]

  • 17. Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.
    Beaulieu YB, Leon Machado JA, Ethier S, Gaudreau L, Steimle V.
    PLoS One; 2016 Jan 27; 11(2):e0148753. PubMed ID: 26871568
    [Abstract] [Full Text] [Related]

  • 18. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines.
    Tschickardt ME, Lu Y, Jacim M, Ussery GD, Steimle V, Mach B, Blanck G.
    Int J Cancer; 1995 Aug 09; 62(4):461-5. PubMed ID: 7635572
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E, Greer SF, Zhu XS, Ting JP.
    Mol Cell Biol; 2003 May 09; 23(9):3091-102. PubMed ID: 12697811
    [Abstract] [Full Text] [Related]

  • 20. Suppression of MHC class II expression by human class II trans-activator constructs lacking the N-terminal domain.
    Yun S, Gustafsson K, Fabre JW.
    Int Immunol; 1997 Oct 09; 9(10):1545-53. PubMed ID: 9352360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.